State Street Corp Macrogenics Inc Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Macrogenics Inc stock. As of the latest transaction made, State Street Corp holds 1,409,312 shares of MGNX stock, worth $2.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,409,312

Previous 1,462,532 3.64%

Holding current value

$2.07 Million

Previous $4.75 Million 62.36%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.26 - $3.49 $67,057 - $185,737	-53,220 Reduced 3.64%	1,409,312 $1.79 Million
Q4 2024 Feb 14, 2025	BUY	$3.18 - $4.46 $111,751 - $156,733	35,142 Added 2.46%	1,462,532 $4.75 Million
Q3 2024 Nov 14, 2024	SELL	$3.0 - $5.55 $345,600 - $639,360	-115,200 Reduced 7.47%	1,427,390 $4.7 Million
Q2 2024 Aug 14, 2024	SELL	$3.31 - $18.51 $9.42 Million - $52.7 Million	-2,847,057 Reduced 64.86%	1,542,590 $6.56 Million
Q1 2024 May 15, 2024	BUY	$9.77 - $21.47 $21.6 Million - $47.6 Million	2,215,625 Added 101.91%	4,389,647 $64.6 Million
Q4 2023 Feb 14, 2024	BUY	$4.48 - $10.11 $3.91 Million - $8.83 Million	873,621 Added 67.18%	2,174,022 $20.9 Million
Q3 2023 Nov 14, 2023	BUY	$4.48 - $6.19 $448 - $619	100 Added 0.01%	1,300,401 $6.06 Million
Q2 2023 Aug 14, 2023	SELL	$4.62 - $7.54 $13,698 - $22,356	-2,965 Reduced 0.23%	1,300,301 $6.96 Million
Q1 2023 May 15, 2023	BUY	$4.82 - $7.24 $57,131 - $85,815	11,853 Added 0.92%	1,303,266 $9.34 Million
Q4 2022 Feb 14, 2023	SELL	$3.34 - $6.98 $286,875 - $599,519	-85,891 Reduced 6.24%	1,291,413 $8.67 Million
Q3 2022 Nov 15, 2022	BUY	$3.01 - $5.22 $327,337 - $567,675	108,750 Added 8.57%	1,377,304 $4.77 Million
Q2 2022 Aug 15, 2022	SELL	$2.25 - $9.99 $5.12 Million - $22.7 Million	-2,276,170 Reduced 64.21%	1,268,554 $3.74 Million
Q1 2022 May 16, 2022	BUY	$8.12 - $16.9 $5.13 Million - $10.7 Million	632,054 Added 21.7%	3,544,724 $31.2 Million
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $479,066 - $658,828	-30,111 Reduced 1.02%	2,912,670 $46.7 Million
Q3 2021 Nov 15, 2021	SELL	$19.74 - $28.7 $5.7 Million - $8.29 Million	-288,778 Reduced 8.94%	2,942,781 $61.6 Million
Q2 2021 Aug 16, 2021	BUY	$20.49 - $35.63 $11.5 Million - $20 Million	562,389 Added 21.07%	3,231,559 $86.8 Million
Q1 2021 May 17, 2021	BUY	$18.99 - $33.2 $1.74 Million - $3.05 Million	91,807 Added 3.56%	2,669,170 $85 Million
Q4 2020 Feb 16, 2021	BUY	$19.41 - $26.0 $5.2 Million - $6.96 Million	267,695 Added 11.59%	2,577,363 $58.9 Million
Q3 2020 Nov 10, 2020	BUY	$24.69 - $31.6 $18.3 Million - $23.4 Million	740,388 Added 47.18%	2,309,668 $58.2 Million
Q2 2020 Aug 14, 2020	SELL	$5.2 - $29.12 $1.8 Million - $10.1 Million	-346,568 Reduced 18.09%	1,569,280 $43.8 Million
Q1 2020 May 11, 2020	BUY	$4.28 - $12.11 $8.2 Million - $23.2 Million	1,915,848 New	1,915,848 $11.2 Million

Others Institutions Holding MGNX

# of Institutions

117

Shares Held

51.4M

Call Options Held

45.1K

Put Options Held

143K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $90.3M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Macrogenics Inc Transaction History